Silexion Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2013	FY 2012
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Market Capitalization	4	3	42	-	-
Market Cap Growth	-	-92.33%	-	-	-
Enterprise Value	7	1	41	-	-
Last Close Price	7.40	30.15	1464.75	-	-
PB Ratio	-	-0.81	13.99	-	-
Debt / Equity Ratio	-1.13	-1.13	0.06	-	-
Quick Ratio	0.34	0.34	2.09	3.64	10.47
Current Ratio	0.64	0.64	2.27	3.85	10.64
Return on Equity (ROE)	-	-	-	-116.66%	-
Return on Assets (ROA)	-193.54%	-193.54%	-	-62.13%	-
Return on Capital (ROIC)	-427.70%	-427.70%	-	-73.07%	-
Earnings Yield	-396.10%	-510.30%	-11.77%	-	-
FCF Yield	-202.78%	-261.25%	-10.81%	-	-

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q